For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 1.5 to 3.0 mg Cariprazine | 1.5 to 3.0 mg Cariprazine capsules, orally administrated once daily for 8 weeks | None | None | 2 | 75 | 52 | 75 | View |
| Placebo | Matching placebo capsules, orally administered for 8 weeks | None | None | 2 | 77 | 51 | 77 | View |
| 0.25 to 0.75 mg Cariprazine | Cariprazine capsules 0.25 to 0.75 mg was orally administrated once daily for 8 weeks | None | None | 2 | 75 | 48 | 75 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Bipolar disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Abortion spontaneous | SYSTEMATIC_ASSESSMENT | Pregnancy, puerperium and perinatal conditions | MeDRA version 13.0 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Bipolar I disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Suicidal ideation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Suicidal attempt | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Akathisia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | MeDRA version 13.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | MeDRA version 13.0 | View |
| Weight Increase | SYSTEMATIC_ASSESSMENT | Investigations | MeDRA version 13.0 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Restlessness | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MeDRA version 13.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Musculoskeletal stiffness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MeDRA version 13.0 | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Migraine | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MeDRA version 13.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA version 13.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Sedation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA version 13.0 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MeDRA version 13.0 | View |